Thrombotic disease

Related records

Broader conditions (5)

• Cardiovascular disorder
• Disease
• Disease by body system or component
• Human disease
• Vascular disorder

Narrower conditions (13)

• Acquired purpura fulminans
• Carotid artery thrombosis
• Cavernous sinus thrombosis
• Coronary thrombosis
• Heparin-induced thrombocytopenia
• Intracranial sinus thrombosis
• Intracranial thrombosis
• Isolated mesenteric vein thrombosis
• Isolated splenic vein thrombosis
• Lateral sinus thrombosis
• Marantic endocarditis
• Portal vein thrombosis
• Sagittal sinus thrombosis

Trials (1,010)

• "Follow-up of Midlines Placed Outside the Intensive Care Unit: What Side Effects? An Observational Study"
• [64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
• A Clinical Study to Compare Two Revascularization Protocols to Treat Non-vital Teeth With Incomplete Root Formation
• A Clinical Trial of IntensiVE Dialysis
• A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days
• A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
• A Complex Contraception Registry
• A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion
• A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A
• A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
• A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
• A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus
• A Novel Point-to-care Method for Fast Evaluation of Viscoelastic Hemostasis Analysis
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis
• A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects
• A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
• A Phase I SAD/MAD and Liver Effect Study of Vitalangio in Venous Thromboembolism Patients .

Approved drugs (55)

• Abciximab
• Acenocoumarol
• Aloxiprin
• Alteplase
• Anagrelide hydrochloride
• Anistreplase
• Antithrombin III human
• Apixaban
• Argatroban
• Aspirin
• Betrixaban
• Bivalirudin
• Cangrelor
• Cangrelor tetrasodium
• Caplacizumab
• Cilostazol
• Clopidogrel
• Dabigatran etexilate
• Dalteparin sodium
• Danaparoid sodium

Drugs in development (81)

• Acetylcysteine Phase 3
• Alfimeprase Phase 3
• Amediplase Phase 3
• Ancrod Phase 3
• Atecegatran metoxil Phase 2
• Avidin Phase 3
• AZD-8165 Phase 1
• Bemiparin Phase 3
• Beraprost Phase 2
• Bervastatin Phase 2
• BMS-962212 Phase 1
• BMS-986120 Phase 1
• BMS-986141 Phase 2
• Brinolase Phase 2
• Busulfan Phase 3
• Carbaspirin calcium Phase 2
• Carboplatin Phase 2
• Cloricromen Phase 2
• Clorindione Phase 2
• Cyclophosphamide Phase 3

Other linked drugs (10)

• AZD-6482
• Biciromab
• Dextran
• Domitroban
• Fradafiban
• Isoquercetin
• Itazigrel
• Lansoprazole
• Satigrel
• Vonoprazan fumarate